BSE Live
Dec 11, 16:01Prev. Close
124.15
Open Price
124.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 11, 15:52Prev. Close
125.21
Open Price
123.10
Bid Price (Qty.)
126.29 (2520)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Indo US Bio-Tech (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 2.86 | 2.81 | 2.04 | 0.00 | 0.24 | |
| Net CashFlow From Operating Activities | -0.79 | -3.17 | -0.88 | 0.00 | -2.58 | |
| Net Cash Used In Investing Activities | -0.59 | -2.56 | 0.31 | 0.00 | -0.11 | |
| Net Cash Used From Financing Activities | 1.49 | 5.74 | 0.59 | 0.00 | 2.78 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.12 | 0.01 | 0.02 | 0.00 | 0.10 | |
| Cash And Cash Equivalents Begin of Year | 0.08 | 0.07 | 0.05 | 0.00 | 0.01 | |
| Cash And Cash Equivalents End Of Year | 0.20 | 0.08 | 0.07 | 0.00 | 0.10 |
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017